Clinical Trial Update: Effect of Brodalumab Compared to Placebo on Vascular Inflammation in Moderate-to-severe Psoriasis [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing the effect of brodalumab versus placebo on vascular inflammation in moderate-to-severe psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• brodalumab (brodalumab)

Snippet

Sponsor: Aarhus University Hospital | Conditions: Psoriasis | Phase 4 | Status: UNKNOWN